Menopausal Hormone Therapy and Breast Cancer Phenotype: Does Dose Matter?

@article{ElisabethRGarwood2008MenopausalHT,
  title={Menopausal Hormone Therapy and Breast Cancer Phenotype: Does Dose Matter?},
  author={BS ElisabethR.Garwood and MPH Anjali S. Kumar and Veronica Shim},
  journal={Annals of Surgical Oncology},
  year={2008},
  volume={15},
  pages={2526-2532}
}
Duration and type of menopausal hormone therapy (HT) has been associated with increased breast cancer risk and the development of estrogen receptor (ER)-positive tumors. The effect of HT dose on breast cancer tumor characteristics remains undefined. We sought to determine if HT dosing regimens influence breast cancer phenotype. We conducted a retrospective review of incident female breast cancers occurring in the year 2003 listed in the Kaiser Permanente Northern California Cancer Registry… CONTINUE READING